Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can light therapy or special skincare tame rosacea redness? a trial puts them to the test

NCT ID NCT07729540

Disease control Sponsor: Medical University of Silesia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This study compares three ways to reduce facial redness in adults with a common form of rosacea: intense pulsed light (IPL) treatments alone, a professional anti-redness skincare regimen alone, or both combined. Researchers will use both doctor ratings and advanced skin-imaging tools to measure changes in redness and skin texture. The goal is to find out which strategy works best for managing this chronic skin condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intense Pulsed Light (IPL) and a targeted anti-redness dermocosmetic regimen
What this could lead to
If successful, this could identify the most effective approach—IPL, skincare, or both—for managing persistent facial redness in rosacea.
What could go wrong
This is a small, early-stage comparative study with 60 participants, so results may not apply broadly. IPL can cause temporary redness or discomfort, and skincare effects may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 57 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients with a dermatologist-confirmed diagnosis of erythematotelangiectatic rosacea Exclusion Criteria: * Age under 18 years * Pregnancy or breastfeeding * Predisposition to keloid or hypertrophic scarring * Use of systemic or topical retinoids, antibiotics, or hormonal therapy within the washout period specified for each agent * Chemical peeling within one month * Laser treatment or phototherapy within three months * Photosensitizing medications or herbal preparations * Inflammatory dermatoses other than rosacea * Autoimmune disease * Active skin infection in the treatment area

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rosacea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Erythema rosacea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rosacea

Contacts and locations

Locations

  • Medical University of Silesia

    Sosnowiec, 41-200, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.